Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1.
Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1.
复制标题
DOI:
10.1038/s41598-023-45412-9
复制
发表时间:
2023-11-03
影响因子:
4.6
通讯作者:
Peppa, Dimitra
中科院分区:
文献类型:
--
作者:
Alrubayyi, Aljawharah;Touizer, Emma;Hameiri-Bowen, Dan;Charlton, Bethany;Gea-Mallorqui, Ester;Hussain, Noshin;da Costa, Kelly A. S.;Ford, Rosemarie;Rees-Spear, Chloe;Fox, Thomas A.;Williams, Ian;Waters, Laura;Barber, Tristan J.;Burns, Fiona;Kinloch, Sabine;Morris, Emma;Rowland-Jones, Sarah;McCoy, Laura E.;Peppa, Dimitra
Natural killer (NK) cell subsets with adaptive properties are emerging as regulators of vaccine-induced T and B cell responses and are specialized towards antibody-dependent functions contributing to SARS-CoV-2 control. Although HIV-1 infection is known to affect the NK cell pool, the additional impact of SARS-CoV-2 infection and/or vaccination on NK cell responses in people living with HIV (PLWH) has remained unexplored. Our data show that SARS-CoV-2 infection skews NK cells towards a more differentiated/adaptive CD57+FcεRIγ− phenotype in PLWH. A similar subset was induced following vaccination in SARS-CoV-2 naïve PLWH in addition to a CD56bright population with cytotoxic potential. Antibody-dependent NK cell function showed robust and durable responses to Spike up to 148 days post-infection, with responses enriched in adaptive NK cells. NK cell responses were further boosted by the first vaccine dose in SARS-CoV-2 exposed individuals and peaked after the second dose in SARS-CoV-2 naïve PLWH. The presence of adaptive NK cells associated with the magnitude of cellular and humoral responses. These data suggest that features of adaptive NK cells can be effectively engaged to complement and boost vaccine-induced adaptive immunity in potentially more vulnerable groups such as PLWH.
登录
查看更多内容
DOI:
10.1016/j.xcrm.2021.100290
发表时间:
2021-06-15
期刊:
Cell reports. Medicine
影响因子:
--
作者:
Anand SP;Prévost J;Nayrac M;Beaudoin-Bussières G;Benlarbi M;Gasser R;Brassard N;Laumaea A;Gong SY;Bourassa C;Brunet-Ratnasingham E;Medjahed H;Gendron-Lepage G;Goyette G;Gokool L;Morrisseau C;Bégin P;Martel-Laferrière V;Tremblay C;Richard J;Bazin R;Duerr R;Kaufmann DE;Finzi A
通讯作者:
Finzi A
影响因子:
4.7
作者:
通讯作者:
--
DOI:
10.1093/cid/ciaa1605
发表时间:
2021-10-05
期刊:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子:
--
作者:
Geretti AM;Stockdale AJ;Kelly SH;Cevik M;Collins S;Waters L;Villa G;Docherty A;Harrison EM;Turtle L;Openshaw PJM;Baillie JK;Sabin CA;Semple MG
通讯作者:
Semple MG
影响因子:
7.7
作者:
Fielding, Ceri Alan;Sabberwal, Pragati;Williamson, James C.;Greenwood, Edward J. D.;Crozier, Thomas W. M.;Zelek, Wioleta;Seow, Jeffrey;Graham, Carl;Huettner, Isabella;Edgeworth, Jonathan D.;Price, David A.;Morgan, Paul B.;Ladell, Kristin;Eberl, Matthias;Humphreys, Ian R.;Merrick, Blair;Doores, Katie;Wilson, Sam J.;Lehner, Paul J.;Wang, Eddie C. Y.;Stanton, Richard J.
通讯作者:
Stanton, Richard J.
影响因子:
6.4
作者:
Herrera L;Martin-Inaraja M;Santos S;Inglés-Ferrándiz M;Azkarate A;Perez-Vaquero MA;Vesga MA;Vicario JL;Soria B;Solano C;De Paz R;Marcos A;Ferreras C;Perez-Martinez A;Eguizabal C
通讯作者:
Eguizabal C